Metastatic Pancreatic Carcinoma Clinical Trials

24 clinical trials for Metastatic Pancreatic Carcinoma across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours — RECRUITING · PHASE1
• Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors — RECRUITING · PHASE1
• Short-term fasting and individualized nutrition accompanying chemotherapy for metastatic pancreatic cancer – a randomised controlled 2-arm intervention study — RECRUITING
• HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients — RECRUITING · PHASE2
• Intravital Microscopy in Human Solid Tumors — RECRUITING · NA
• A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations — RECRUITING · PHASE2
• Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis — RECRUITING · PHASE2
• CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors — RECRUITING · PHASE2
• A Phase III, open label, multicentre randomised clinical study comparing Acelarin (NUC-1031) with Gemcitabine in patients with metastatic pancreatic carcinoma. — OTHER · PHASE3
• Phase II Study for the Evaluation of the Efficacy of Gemcitabine plus Erlotinib in Rash-positive Patients with metastatic pancreatic cancer and good risk factors — COMPLETED · PHASE2
• Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations — ACTIVE_NOT_RECRUITING · PHASE2
• M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery — ACTIVE_NOT_RECRUITING · PHASE1
• Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events — ACTIVE_NOT_RECRUITING · NA
• BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion — NOT_YET_RECRUITING · PHASE1
• Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer — TERMINATED · PHASE1
• Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) — ACTIVE_NOT_RECRUITING · PHASE1
• Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study — COMPLETED · PHASE2
• Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic Cancer — NOT_YET_RECRUITING · PHASE2
• Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E Mutation — TERMINATED · PHASE2
• Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver Metastases — TERMINATED · PHASE1
• A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic Carcinoma — TERMINATED · PHASE1
• A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer — COMPLETED · PHASE1
• Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer — COMPLETED · PHASE2

Refine this search